Trial NCT00167206

View at ClinicalTrials.gov 
Org. Study IDs: 0312M54991
Secondary IDs: MT2003-18

Last trial update was posted on 2019-08-26

MeSH Interventions

Cyclophosphamide Fludarabine

MeSH Conditions

Anemia Fanconi Anemia Fanconi Syndrome

Other Conditions


Stopping Reasons

Treatment with thymic shielding found safe, another study started.

Limitations And Caveats

Study ended early as thymic shielding was found to be safe. Therefore, a new study was designed using thymic shielding.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID